Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension
Status:
COMPLETED
Trial end date:
2003-12-05
Target enrollment:
Participant gender:
Summary
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial tested the hypothesis that for the same blood-pressure control, valsartan would reduce cardiac morbidity and mortality more than amlodipine in hypertensive patients at high cardiovascular risk. The present study investigates effects of valsartan and amlodipine on pre-specified secondary kidney outcomes.